Pay in 4 interest-free payments of $6.82 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
Semaglutide Dosing Considerations for Reduced Kidney Function Unlike some medications, semaglutide does not require dose reduction based on kidney function because it is eliminated primarily through amino acid metabolism rather than renal excretion
Revlimid (lenalidomide) Disease area(s): Oncology/hematology Manufacturer(s): Bristol Myers Squibb 2024 Sales (USD): $5.77 billion Why it sold so well: In 2024, BMS Revlimid generated $5.77 billion in global revenue, maintaining its position as one of the companys top-selling products despite facing generic competition
ESZ: Early Schizophrenia
Patients should report suspected side effects via the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk)
US$ 23.02
US$ 26.83
US$ 20.59
US$ 28.52
US$ 23.55
